Spontaneous ilio-psoas hematomas complicating intensive care unit hospitalizations.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
06
2018
accepted:
20
01
2019
entrez:
23
2
2019
pubmed:
23
2
2019
medline:
13
11
2019
Statut:
epublish
Résumé
Ilio-psoas hematoma is a potentially lethal condition that can arise during hospital stay. However, neither the incidence nor the prognosis of patients whose stay in intensive care units (ICU) is complicated by a iatrogenic ilio-psoas hematoma is known. A bicentric retrospective study was conducted to compile the patients who developed an ilio-psoas hematoma while they were hospitalized in ICU between January 2009 and December 2016. Their biometric characteristics, pre-existing conditions, the circumstances in which the hematoma was diagnosed, the treatments they received and their prognosis were recorded. Forty patients were diagnosed with an ilio-psoas hematoma during their ICU stay. The incidence of this complication was 3.8 cases for 1000 admissions, taking into account only patients who stayed more than three days in ICU. The median age of patients was 74 years old and the median time between admission and the diagnosis of ilio-psoas hematoma was 12.6 days. A large proportion of them was obese (42.5%) and/or under dialysis (50%) prior to developing their hematoma. Ninety-five percent of the patients had heparin at prophylactic or therapeutic doses. Only 10% of them were above the therapeutic range of anticoagulation. The ICU mortality rate was of 50% following this complication (versus a general mortality rate of 22% for the patients without IPH over the same period of time). Patients with IPH that were complicated by disseminated intravascular coagulopathy had a significantly higher mortality rate than those with IPH and no disseminated intravascular coagulopathy (OR 6.91, 95% CI [1.28; 58.8], p = 0.04). Age, anticoagulation, a high body mass index and dialysis seem to be risk factors of developing an ilio-psoas hematoma in ICU. Iatrogenic ilio-psoas hematomas complicated by disseminated intravascular coagulopathies are more at risk of leading to death. It is noteworthy that activated partial thromboplastin time above the therapeutic range was not a good predictor of developing a hematoma for patients who received unfractioned heparin therapy.
Sections du résumé
BACKGROUND
Ilio-psoas hematoma is a potentially lethal condition that can arise during hospital stay. However, neither the incidence nor the prognosis of patients whose stay in intensive care units (ICU) is complicated by a iatrogenic ilio-psoas hematoma is known.
METHODS
A bicentric retrospective study was conducted to compile the patients who developed an ilio-psoas hematoma while they were hospitalized in ICU between January 2009 and December 2016. Their biometric characteristics, pre-existing conditions, the circumstances in which the hematoma was diagnosed, the treatments they received and their prognosis were recorded.
RESULTS
Forty patients were diagnosed with an ilio-psoas hematoma during their ICU stay. The incidence of this complication was 3.8 cases for 1000 admissions, taking into account only patients who stayed more than three days in ICU. The median age of patients was 74 years old and the median time between admission and the diagnosis of ilio-psoas hematoma was 12.6 days. A large proportion of them was obese (42.5%) and/or under dialysis (50%) prior to developing their hematoma. Ninety-five percent of the patients had heparin at prophylactic or therapeutic doses. Only 10% of them were above the therapeutic range of anticoagulation. The ICU mortality rate was of 50% following this complication (versus a general mortality rate of 22% for the patients without IPH over the same period of time). Patients with IPH that were complicated by disseminated intravascular coagulopathy had a significantly higher mortality rate than those with IPH and no disseminated intravascular coagulopathy (OR 6.91, 95% CI [1.28; 58.8], p = 0.04).
CONCLUSION
Age, anticoagulation, a high body mass index and dialysis seem to be risk factors of developing an ilio-psoas hematoma in ICU. Iatrogenic ilio-psoas hematomas complicated by disseminated intravascular coagulopathies are more at risk of leading to death. It is noteworthy that activated partial thromboplastin time above the therapeutic range was not a good predictor of developing a hematoma for patients who received unfractioned heparin therapy.
Identifiants
pubmed: 30794573
doi: 10.1371/journal.pone.0211680
pii: PONE-D-18-17977
pmc: PMC6386274
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0211680Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Emerg Med. 2012 Aug;43(2):e157-61
pubmed: 21911282
Crit Care Med. 2006 Mar;34(3):625-31
pubmed: 16521260
J Chir (Paris). 1997;134(9-10):382-9
pubmed: 9682753
Arch Orthop Trauma Surg (1978). 1982;99(3):195-7
pubmed: 7073448
Stroke. 2013 Jun;44(6):1584-9
pubmed: 23549133
Crit Care Med. 2016 Oct;44(10):e930-9
pubmed: 27322364
Intensive Care Med. 2003 Feb;29(2):325-8
pubmed: 12594595
Ann Intensive Care. 2016 Dec;6(1):8
pubmed: 26782681
Intensive Care Med. 2013 Oct;39(10):1695-703
pubmed: 23793890
Ann Intensive Care. 2017 Dec 2;7(1):117
pubmed: 29197958
Medicine (Baltimore). 2015 Nov;94(47):e2161
pubmed: 26632750
Platelets. 2013;24(3):213-8
pubmed: 22647149
Crit Care Med. 1998 Aug;26(8):1337-45
pubmed: 9710091
Int J Clin Pract. 2008 Oct;62(10):1604-13
pubmed: 17949429
Semin Thromb Hemost. 2004 Oct;30(5):579-89
pubmed: 15497100
Crit Care. 2016 Apr 12;20:100
pubmed: 27072503
Am J Clin Pathol. 2013 Apr;139(4):450-6
pubmed: 23525615
Semin Thromb Hemost. 1999;25(4):407-18
pubmed: 10548073
Medicine (Baltimore). 2003 Jul;82(4):257-62
pubmed: 12861103
Crit Care Med. 2015 Mar;43(3):519-26
pubmed: 25479111